DR. DAVID CADWELL BARTELS DO NPI 1245492768

NPI Information

  • NPI: 1245492768
  • Provider Name: DR. DAVID CADWELL BARTELS, DO
  • Classification: Internal Medicine - 207RH0003X
  • Specialization: Hematology & Oncology
  • Entity Type: Individual
  • PECOS Registration: Yes
  • Address: 3815 N SCHREIBER WAY STE 101
    COEUR D ALENE, ID
    ZIP 83815
  • Phone: (208) 755-2804

Map and Directions

Get Directions

NPI Details

DR. David Cadwell Bartels, DO is a hematology and oncology internal medicine in Coeur D Alene, ID with 18 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. David Cadwell Bartels, DO NPI is 1245492768. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

The provider's business location address is:

3815 N SCHREIBER WAY STE 101
COEUR D ALENE, ID
ZIP 83815-362
Phone: (208) 755-2804
Fax: (208) 765-0277

The NPI 1245492768 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

  • Injection, nivolumab, 1 mg (HCPCS:J9299)
  • Injection, denosumab, 1 mg (HCPCS:J0897)
  • Injection, pembrolizumab, 1 mg (HCPCS:J9271)
  • Injection, paclitaxel, 1 mg (HCPCS:J9267)
  • Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
  • Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg (HCPCS:Q5107)
  • Injection, ipilimumab, 1 mg (HCPCS:J9228)
  • Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg (HCPCS:J1568)
  • Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
  • Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
  • Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
  • Injection, fulvestrant, 25 mg (HCPCS:J9395)
  • Blood test, comprehensive group of blood chemicals (HCPCS:80053)
  • Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
  • Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
  • Injection of additional new drug or substance into vein (HCPCS:96375)
  • Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
  • Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
  • Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
  • Injection, fluorouracil, 500 mg (HCPCS:J9190)
  • Injection, carboplatin, 50 mg (HCPCS:J9045)
  • Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
  • Injection of drug or substance under skin or into muscle (HCPCS:96372)
  • Injection, pegfilgrastim-apgf, biosimilar, (nyvepria), 0.5 mg (HCPCS:Q5122)
  • Insertion of needle into vein for collection of blood sample (HCPCS:36415)
  • Unclassified drugs (HCPCS:J3490)
  • Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
  • Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
  • Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
  • Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
  • Infusion, normal saline solution, 250 cc (HCPCS:J7050)
  • Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
  • Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
  • Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
  • Injection, fosnetupitant 235 mg and palonosetron 0.25 mg (HCPCS:J1454)
  • Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
  • Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
  • Telephone medical discussion with physician, 11-20 minutes (HCPCS:99442)
  • Automated urinalysis test (HCPCS:81003)
  • Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
  • Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted l (HCPCS:G0498)
  • Irrigation of implanted venous access drug delivery device (HCPCS:96523)
  • Infusion into a vein for hydration, each additional hour (HCPCS:96361)
  • New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
  • Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
  • Collection of blood sample from implanted device (HCPCS:36591)
  • Drawing of blood for a medical problem (HCPCS:99195)
  • New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
  • Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
  • Injection of drug or substance into vein (HCPCS:96374)
  • Telephone medical discussion with physician, 5-10 minutes (HCPCS:99441)
  • Telephone medical discussion with physician, 21-30 minutes (HCPCS:99443)

The enumeration date for this NPI number is 6/26/2008 and was last updated on 8/25/2023.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

No. Taxonomy Code Taxonomy Clasification Taxonomy Specialization License Number License State Primary
1207RH0000XInternal MedicineHematologyO-0817IDAHONo
2207RX0202XInternal MedicineMedical OncologyO-0817IDAHONo
3207RH0003XInternal MedicineHematology & OncologyO-0817IDAHOYes

What is NPI?

NPI stands for National Provider Identifier. The NPI is a 10-digit identification number that is completely unique. The NPI number by itself does not contain any identifiable information such as a provider’s speciality or location. The NPI is assigned to individuals or organizacions for their lifespan and it is independent of key provider information type updates like a change of practices, location or speciality.

This page was last updated on: 11/21/2025

NPI Synchronization or Removal

All materials and services on this site are provided on an "as is" and "as available" basis without warranty of any kind. The NPI record is maintained by the National Plan & Provider Enumeration System (NPPES) and anyone may request this information and other NPPES health care provider data from HHS under The Freedom of Information Act (FOIA), Title 5 of the United States Code, section 552. To update the NPI records please contact the NPPES.